Analyst firms · Barclays · TXN

Barclays TXN price target and rating history

Texas Instruments Incorporated (TXN) · Technology

Barclays rates Texas Instruments Incorporated (TXN) Equal Weight with a $250 price target, as of its latest action on Apr 23, 2026. It has published 6 rating actions on TXN since January 2022, including 2 upgrades and 1 downgrade. Across 11 firms with a TXN price target in the last 12 months, the median target is $300. Barclays's $250 is 17% below that.

Current rating
Equal Weight
Price target
$250
Median target, all firms
$300
Actions on TXN
6

Barclays price target on TXN

$250$188$1252023202420252026
Barclays price target on TXN, each point a stated target, January 2022 to April 2026.

Every Barclays rating on TXN

How other firms rate TXN

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
DZ BankHold$300Oct 28, 2026
Arete ResearchBuy$405Jul 29, 2026
Seaport Research PartnersBuy$400May 22, 2026
MizuhoNeutral$300May 19, 2026
Cantor FitzgeraldNeutral$300May 13, 2026
BofA SecuritiesBuy$320Apr 23, 2026
BarclaysEqual Weight$250Apr 23, 2026
StifelBuy$250Apr 9, 2026
TD CowenBuy$240Jan 28, 2026
BNP Paribas ExaneNeutral$190Jan 22, 2026
Goldman SachsSell$156Dec 15, 2025

Questions about Barclays and TXN

What is Barclays's price target for TXN?
Barclays's latest stated price target for Texas Instruments Incorporated (TXN) is $250, from its action on Apr 23, 2026.
What is Barclays's rating on TXN?
Barclays rates TXN Equal Weight, a neutral rating, as of Apr 23, 2026.
When did Barclays last change its view on TXN?
On Apr 23, 2026, Barclays upgrades to Equal Weight from Underweight, price target $250.
How does Barclays's TXN target compare with other analysts?
Across 11 firms with a TXN price target in the last 12 months, the median target is $300. Barclays's $250 is 17% below that.

More TXN rating histories

All Barclays ratingsTXN news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.